Canalblog
Editer l'article Suivre ce blog Administration + Créer mon blog
Publicité
dfdfdfd
26 avril 2010

GLOBAL LONGITUDINAL STUDY OF OSTEOPOROSIS IN WOMEN: UNIVERSITY OF ALABAMA

Underscoring what researchers call a serious   international public health concern, results from the Global<a href="http://www.tiffanyjewelryweb.com/tiffany-cushion-hoop-earrings-p-171.html">Tiffany Cushion Hoop earrings</a> Study   of Osteoporosis in Women (GLOW) reveal that many women at an elevated level of   risk for osteoporosis-associated fractures fail to perceive the implications of   the risk factors.</p>
<p>The University of Alabama at Birmingham (UAB) is one   of 17 GLOW study sites in the world.</p>
<p>Study results showed that among postmenopausal women   from 10 countries in Europe, North America and Australia diagnosed with   osteoporosis - a condition putting them at high risk for fractures- only 43   percent thought their risk of a fracture was higher than other women their   age.</p>
<p>&quot;Additionally, only one in three women in GLOW who   reported two or more major risk factors for fracture perceived themselves as   being at higher risk for fracture than their age-matched peers,&quot; said UAB's   Kenneth Saag, M.D., a study investigator and professor of medicine in the   Division of Clinical Immunology and Rheumatology.</p>
<p>This latest study from GLOW, which is based at the   Center for Outcomes Research at the University of Massachusetts Medical School,   was published today, April 2, online in the journal Osteoporosis International   and included more than 60,000 postmenopausal women in 10 countries.</p>
<p>&quot;We've found that many women aren't making the   connection between their risk factors and the serious consequences of   fractures,&quot; said the lead author Ethel Siris, M.D., director of the Toni Stabile   Osteoporosis Center of the Columbia University Medical Center, New   York-Presbyterian Hospital. &quot;Without a clear understanding of their risks, women   cannot begin to protect themselves from fracture.&quot;</p>
<p>One in two women will suffer an osteoporosis-related   fracture after age 50; these fractures often carry with them chronic pain,   reduced mobility, loss of independence and - in the case of hip fracture - an   increased risk of death. Because the likelihood of fractures increases   substantially with age, fracture numbers are projected to rise as the population   ages. Osteoporosis-related fractures are an international public health problem;   in addition to the human suffering associated with these fractures, they also   are the source of enormous health-care costs.</p>
<p>Improved education of physicians and postmenopausal   women about osteoporosis risk factors is urgently needed, according to the study   authors. Osteoporosis causes bones to become fragile and more likely to break.   If left untreated, the disease can progress painlessly until a fracture occurs.   Several risk factors for fractures have been identified and should be considered   by physicians treating women age 55 and older:</p>
<p>* older age</p>
<p>* low weight</p>
<p>* parental hip fracture</p>
<p>* personal history of fracture (clavicle, arm, wrist,   spine, rib, hip, pelvis, upper leg, lower leg, ankle) since age 45</p>
<p>* two or more falls in the past year</p>
<p>* current use of cortisone or <a href="http://www.tiffanyjewelryweb.com/tiffany-cushion-hoop-earrings-p-171.html">Tiffany Cushion Hoop earrings</a>(steroids   often prescribed for a number of medical conditions)</p>
<p>* rheumatoid arthritis</p>
<p>* cigarette smoking</p>
<p>* consumption of three or more alcoholic beverages   daily.</p>
<p>Other risk factors include a variety of medical   conditions and medications. Tools for diagnosis and risk assessment, including   bone-density testing and the World Health Organization FRAX fracture   risk-assessment tool, are widely available; still, the connection between   identified risk factors and serious fracture outcomes is not being made by a   majority of women at highest risk. Because many fractures can be prevented by   appropriate treatment, it is important that elevated risk be recognized.</p>
<p>&quot;We hope the insight we obtain from GLOW will help   physicians and patients work together to identify those at risk for fracture and   to enhance understanding of the meaning of that risk,&quot; said Siris. &quot;Education is   critical if we are to reduce the burden of fractures worldwide.&quot;</p>
<p>GLOW is a prospective, international cohort study of   women 55 years of age and older who visited their primary-care physician during   the two years prior to enrollment in the study. More than 60,000 women were   recruited by more than 700 primary-care physicians in 17 cities in 10 countries   (Australia, Belgium, Canada, France, Germany, Italy, Netherlands, Spain, United   Kingdom and the United States.) GLOW is gathering information on osteoporosis   risk factors, treatments, patient behaviors and fracture outcomes during a   five-year period. Self-perceived risk of fracture was assessed using a   five-point scale ranging from &quot;much lower&quot; to &quot;much higher&quot; risk than other   women of the same age.</p>
<p>Of the 28,000 U.S. women who participated in GLOW,   5,061 were enrolled through UAB's internal medicine or family practice clinics.   Almost a quarter (23 percent) of these women reported an osteoporosis diagnosis,   23 percent had a previous fracture, 12 percent were low weight, 41 percent   reported recent falls and 18 percent a parental hip fracture. Despite the high   prevalence of risk factors, only 35 percent of women with two or more major risk   factors perceived themselves to be at higher risk of a fracture than their   peers. This failure by women to appreciate their personal risk of fracture   presents a barrier to them receiving appropriate management and safe, effective   treatments.</p>
<p>GLOW is supported by a grant from The Alliance for   Better Bone Health (formerly Sanofi-aventis and P&amp;G <a href="http://www.tiffanyjewelryweb.com/atlas-earring-p-172.html">Atlas earring</a>, now   Sanofi-aventis and Warner Chilcott) and is being directed by The Center for   Outcomes Research, University of Massachusetts Medical School.For more   information please contact: Sarabjit Jagirdar

Publicité
Publicité
Commentaires
Publicité